Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Open in API
Filings indexed 829 across all filing types
Latest filing 2023-08-31 M&A Activity
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
M&A Activity Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC by Zevra Therapeutics, Inc. It announces a merger agreement and related events, including a communication to employees and a conference call for investors. The document does not contain full financial statements or detailed financial analysis but rather reports on a significant corporate event (merger) and related disclosures. The presence of a merger agreement and the nature of the announcement indicate this is related to M&A activity. The document is not a full annual or quarterly report, nor is it an earnings release or other financial supplement. Therefore, the appropriate classification is M&A Activity (TAR).
2023-08-31 English
8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 30, 2023, by Zevra Therapeutics, Inc. The content describes the entry into a material definitive agreement, specifically a Merger Agreement between Zevra Therapeutics and Acer Therapeutics. It details the terms of the merger, conditions, termination rights, and contingent value rights related to the merger. The document is a current report disclosing a significant corporate event (merger agreement) rather than a full financial report, earnings release, or other types of filings. This type of filing is best classified under M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length is substantial and contains detailed merger information, not just an announcement or summary, confirming it is not a mere report publication announcement or regulatory filing. Therefore, the appropriate classification is TAR with high confidence.
2023-08-31 English
425 Filing
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a Merger Agreement between Zevra Therapeutics, Inc. and Acer Therapeutics Inc., detailing the terms, conditions, and contingencies of the merger. This is a clear announcement of a merger transaction rather than a full merger proxy statement or tender offer filing. The document is lengthy (15,000 characters) and contains detailed information about the merger agreement, including termination rights, consideration, and contingent value rights. Given these characteristics, the document fits best under the category of M&A Activity (Code: TAR), which covers announcements and documents related to merger proposals or takeover bids. It is not a full merger proxy statement (MA), nor is it a simple report publication announcement (RPA) or regulatory filing (RNS). Therefore, the classification is TAR with high confidence.
2023-08-31 English
FORM 4
Director's Dealing
2023-08-25 English
FORM 3
Director's Dealing
2023-08-24 English
FORM 10-Q
Interim / Quarterly Report Q2 2023
2023-08-14 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.